EGFR-TKI monotherapy has been utilized for EGFR mutant lung cancer, and EGF monoclonal antibodies, together with chemotherapy, have been used for breast cancer, gastric cancer, and colon cancer, among others. The gene discussed is EGFR; the disease is breast cancer.